CommentaryBreast cancer: delays, dilemmas, and delusions
References (5)
- et al.
Breast cancer screening with mammography: overview of the Swedish randomised trials
Lancet
(1993) - et al.
Influence of clinician workload and patterns of treatment on survival from breast cancer
Lancet
(1995)
Cited by (63)
Diagnostic delay and suboptimal management in persistent idiopathic facial pain and persistent dentoalveolar pain; a cross-sectional study
2019, Oral Surgery, Oral Medicine, Oral Pathology and Oral RadiologyCan we make a portrait of women with inoperable locally advanced breast cancer?
2017, BreastCitation Excerpt :Delays caused by doctors, system barriers and patients play a major role [14]. Doctor delay defines the time period from the first medical visit to the clinical diagnosis or suspect [15]. Such delay has been mainly associated with younger age and presenting with a breast symptom other than a lump [16].
Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional Evaluation
2016, Journal of the American College of SurgeonsIncreasing time delay from presentation until surgical referral for hepatobiliary malignancies
2010, HPBCitation Excerpt :Furthermore there is no consensus on what constitutes a significant TD for cancer patients, although some expert reviews have suggested that a time between presentation and referral for definitive treatment of >30 days is unreasonable and therefore should be defined as constituting a delay in treatment.2 Delayed treatment of many non-HB malignancies is associated with negative effects on survival and disease progression.3–9 Treatment delay in hepatocellular carcinoma (HCC) of >3 months has been associated with tumour progression and decreased survival rates.10